5 Results for "

In silico docking

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "In silico docking" in MCE Product Catalog:

Cat. No.: HY-178955
Research Areas:  

Cancer

EGFR-IN-182 (Compound 4) is an EGFR inhibitor with an IC50 value of 199 nM. EGFR-IN-182 inhibits HSP90 and PI3K, with IC50 values of 5.007 and 13.596 μM respectively. EGFR-IN-182 exhibits strong anti-proliferative activity against MCF-7 and MDA-MB-231 cells. EGFR-IN-182 downregulates Cyclin D1, inducing cell cycle arrest; it enhances the activity of caspase-9, inducing cell apoptosis. EGFR-IN-182 downregulates the expressions of ERK and AKT. EGFR-IN-182 can be used for research on breast cancer .
loading...
    loading...
Cat. No.: HY-161063
CAS No.: 3049475-29-5
Research Areas:  

Cancer

DHFR-IN-14 (compound 32) is a pyrimethamine (Pyr)-type, dihydrofolate reductase (DHFR) inhibitor with potential anticancer activity .
loading...
    loading...
Cat. No.: HY-161064
CAS No.: 3049475-31-9
Research Areas:  

Cancer

DHFR-IN-15 (compound 34) is a dihydrofolate reductase (DHFR) inhibitor with potential anticancer activity. DHFR-IN-15 effectively binds to DHFR in cells, reducing DHFR levels to 10 nM .
loading...
    loading...
Cat. No.: HY-179487
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

α-Glucosidase-IN-102 (Compound 8e) is a competitive inhibitor of α-glucosidase with an IC50 value of 36.2 μM. α-Glucosidase-IN-102 can be used for research on diabetes .
loading...
    loading...
Cat. No.: HY-181824
Target:  

Bacterial

Research Areas:  

Infection

Cholera toxin-IN-1 is a potent competitive inhibitor of cholera toxin B subunit (CTB) with an IC50 value of 11.78 μM. Cholera toxin-IN-1 forms stable hydrogen bonds and hydrophobic interactions. Cholera toxin-IN-1 competitively blocks the binding of CTB to GM1 ganglioside. Cholera toxin-IN-1 can be used for the research of cholera .
loading...
    loading...